Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases

References

• Prusiner SB. The prion diseases. Brain Pathol 1998; 8:499 - 513
   PubMed Web of Science ®Google Scholar
• Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry 2005; 76:906 - 919
   PubMed Web of Science ®Google Scholar
• Ishida C, Okino S, Kitamoto T, Yamada M. Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2005; 76:325 - 329
   PubMed Web of Science ®Google Scholar
• Gregori L, Kovacs GG, Alexeeva I, Budka H, Rohwer RG. Excretion of transmissible spongiform encephalopathy infectivity in urine. Emerg Infect Dis 2008; 14:1406 - 1412
   PubMed Web of Science ®Google Scholar
• Narang HK, Dagdanova A, Xie Z, Yang Q, Chen SG. Sensitive detection of prion protein in human urine. Exp Biol Med (Maywood) 2005; 230:343 - 349
   PubMed Web of Science ®Google Scholar
• Gonzalez-Romero D, Barria MA, Leon P, Morales R, Soto C. Detection of infectious prions in urine. FEBS Lett 2008; 582:3161 - 3166
   PubMed Web of Science ®Google Scholar
• Andrievskaia O, Algire J, Balachandran A, Nielsen K. Prion protein in sheep urine. J Vet Diagn Invest 2008; 20:141 - 146
   PubMed Web of Science ®Google Scholar
• Tatzelt J, Winklhofer KF. Folding and misfolding of the prion protein in the secretory pathway. Amyloid 2004; 11:162 - 172
   PubMed Web of Science ®Google Scholar
• Halliday S, Houston F, Hunter N. Expression of PrPC on cellular components of sheep blood. J Gen Virol 2005; 86:1571 - 1579
   PubMed Web of Science ®Google Scholar
• Brandel JP, Preece M, Brown P, Croes E, Laplanche JL, Agid Y, et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 2003; 362:128 - 130
   PubMed Web of Science ®Google Scholar
• Wientjens DP, Rikken B, Wit JM, Hofman A, Stricker BH. A nationwide cohort study on Creutzfeldt-Jakob disease among human growth hormone recipients. Neuroepidemiology 2000; 19:201 - 205
   PubMed Web of Science ®Google Scholar
• Lemmer K, Mielke M, Pauli G, Beekes M. Decontamination of surgical instruments from prion proteins: in vitro studies on the detachment, destabilization and degradation of PrPSc bound to steel surfaces. J Gen Virol 2004; 85:3805 - 3816
   PubMed Web of Science ®Google Scholar
• Blattler T. Implications of prion diseases for neurosurgery. Neurosurg Rev 2002; 25:195 - 203
   PubMed Web of Science ®Google Scholar
• Peden AH, Ritchie DL, Ironside JW. Risks of transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Folia Neuropathol 2005; 43:271 - 278
   PubMedGoogle Scholar
• Sneath PH. Estimation of the size of the vCJD epidemic. Antonie Van Leeuwenhoek 2004; 86:93 - 103
   PubMed Web of Science ®Google Scholar
• Glatzel M, Ott PM, Linder T, Gebbers JO, Gmur A, Wust W, et al. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol 2003; 2:757 - 763
   PubMedGoogle Scholar
• Spinney L. vCJD epidemic could be first of many, experts warn. Nat Med 2003; 9:1096
   PubMed Web of Science ®Google Scholar
• Trevitt CR, Singh PN. Variant Creutzfeldt-Jakob disease: pathology, epidemiology and public health implications. Am J Clin Nutr 2003; 78:651 - 656
   Google Scholar
• Ramasamy I, Law M, Collins S, Brooke F. Variant Creutzfeldt-Jakob disease and the potential for its accidental transmission following surgery with contaminated instruments: the risk of transmission in Australia. Folia Neuropathol 2003; 41:1 - 10
   PubMedGoogle Scholar
• Pedersen NS, Smith E. Prion diseases: epidemiology in man. Apmis 2002; 110:14 - 22
   PubMed Web of Science ®Google Scholar
• Barnard G, Helmick B, Madden S, Gilbourne C, Patel R. The measurement of prion protein in bovine brain tissue using differential extraction and DELFIA as a diagnostic test for BSE. Luminescence 2000; 15:357 - 362
   PubMed Web of Science ®Google Scholar
• Bellon A, Seyfert-Brandt W, Lang W, Baron H, Groner A, Vey M. Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivity. Journal of General Virology 2003; 84:1921 - 1925
   PubMed Web of Science ®Google Scholar
• Bieschke J, Giese A, Schulz-Schaeffer W, Zerr I, Poser S, Eigen M, Kretzschmar H. Ultrasensitive detection of pathological prion protein aggregates by dual-color scanning for intensely fluorescent targets. Proc Natl Acad Sci USA 2000; 97:5468 - 5473
   PubMed Web of Science ®Google Scholar
• Biffiger K, Zwald D, Kaufmann L, Briner A, Nayki I, Purro M, et al. Validation of a luminescence immunoassay for the detection of PrP(Sc) in brain homogenate. J Virol Methods 2002; 101:79 - 84
   PubMed Web of Science ®Google Scholar
• Jackman R, Schmerr MJ. Analysis of the performance of antibody capture methods using fluorescent peptides with capillary zone electrophoresis with laser-induced fluorescence. Electrophoresis 2003; 24:892 - 896
   PubMed Web of Science ®Google Scholar
• Kenney K, Brechtel C, Takahashi H, Kurohara K, Anderson P, Gibbs CJ Jr. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 2000; 48:395 - 398
   PubMed Web of Science ®Google Scholar
• Klohn PC, Stoltze L, Flechsig E, Enari M, Weissmann C. A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions. Proc Natl Acad Sci USA 2003; 100:11666 - 11671
   PubMed Web of Science ®Google Scholar
• MacGregor I, Hope J, Barnard G, Kirby L, Drummond O, Pepper D, et al. Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components. Vox Sanguinis 1999; 77:88 - 96
   PubMed Web of Science ®Google Scholar
• Oesch B, Doherr M, Heim D, Fischer K, Egli S, Bolliger S, et al. Application of Prionics western blotting procedure to screen for BSE in cattle regularly slaughtered at Swiss abattoirs. Arch Virol Suppl 2000; 189 - 195
   PubMedGoogle Scholar
• Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 2001; 411:810 - 813
   PubMed Web of Science ®Google Scholar
• Safar JG, Scott M, Monaghan J, Deering C, Didorenko S, Vergara J, et al. Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat Biotechnol 2002; 20:1147 - 1150
   PubMed Web of Science ®Google Scholar
• Sayers R. Nunally B, Krull IS. Chemiluminescent ELISA of prion proteins. Prions and Mad Cow Disease 2003;
   Google Scholar
• Schaller O, Fatzer R, Stack M, Clark J, Cooley W, Biffiger K, et al. Validation of a western immunoblotting procedure for bovine PrP(Sc) detection and its use as a rapid surveillance method for the diagnosis of bovine spongiform encephalopathy (BSE). Acta Neuropathol (Berl) 1999; 98:437 - 443
   PubMed Web of Science ®Google Scholar
• Schmerr MJ, Jenny AL, Bulgin MS, Miller JM, Hamir AN, Cutlip RC, Goodwin KR. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. Journal of Chromatography A 1999; 853:207 - 214
   PubMed Web of Science ®Google Scholar
• Zerr I, Bodemer M, Otto M, Poser S, Windl O, Kretzschmar HA, et al. Diagnosis of Creutzfeldt-Jakob disease by two-dimensional gel electrophoresis of cerebrospinal fluid. Lancet 1996; 348:846 - 849
   PubMed Web of Science ®Google Scholar
• Barnard G, Sy M. Krull I. The diagnosis of transmissible spongiform encephalopathies using differential extraction and DELFIA. Prions and Mad Cow Disease 2003; New York Marcel Dekker 277 - 315
   Google Scholar
• Grassi J. Pre-clinical diagnosis of transmissible spongiform encephalopathies using rapid tests. Transfus Clin Biol 2003; 10:19 - 22
   PubMed Web of Science ®Google Scholar
• Meyer RK, Oesch B, Fatzer R, Zurbriggen A, Vandevelde M. Detection of bovine spongiform encephalopathy-specific PrP(Sc) by treatment with heat and guanidine thiocyanate. J Virol 1999; 73:9386 - 9392
   PubMed Web of Science ®Google Scholar
• Safar JG, Geschwind MD, Deering C, Didorenko S, Sattavat M, Sanchez H, et al. Diagnosis of human prion disease. Proc Natl Acad Sci USA 2005; 102:3501 - 3506
   PubMed Web of Science ®Google Scholar
• Kim JI, Wang C, Kuizon S, Xu J, Barengolts D, Gray PC, Rubenstein R. Simple and specific detection of abnormal prion protein by a magnetic bead-based immunoassay coupled with laser-induced fluorescence spectrofluorometry. J Neuroimmunol 2005; 158:112 - 119
   PubMed Web of Science ®Google Scholar
• Frosh A, Smith LC, Jackson CJ, Linehan JM, Brandner S, Wadsworth JD, Collinge J. Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 2004; 364:1260 - 1262
   PubMed Web of Science ®Google Scholar
• Glatzel M. Testing for prions: a novel protocol for vCJD prevalence studies. Lancet 2004; 364:1196 - 1197
   PubMed Web of Science ®Google Scholar
• Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D, et al. Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 2004; 203:733 - 739
   PubMed Web of Science ®Google Scholar
• Furukawa H, Doh-ura K, Okuwaki R, Shirabe S, Yamamoto K, Udono H, et al. A pitfall in diagnosis of human prion diseases using detection of protease-resistant prion protein in urine. Contamination with bacterial outer membrane proteins. J Biol Chem 2004; 279:23661 - 23667
   PubMed Web of Science ®Google Scholar
• Shiga Y, Miyazawa K, Takeda A, Arai H, Doh-ura K, Itoyama Y. Laboratory and imaging studies for the diagnosis of prion disease. Rinsho Shinkeigaku 2003; 43:810 - 812
   PubMedGoogle Scholar
• Kariv-Inbal Z, Halimi M, Dayan Y, Engelstein R, Gabizon R. Characterization of light chain immunoglobulin in urine from animals and humans infected with prion diseases. J Neuroimmunol 2005; 162:12 - 18
   PubMed Web of Science ®Google Scholar
• Serban A, Legname G, Hansen K, Kovaleva N, Prusiner SB. Immunoglobulins in urine of hamsters with scrapie. J Biol Chem 2004; 279:48817 - 48820
   PubMed Web of Science ®Google Scholar
• Will RG, Zeidler M, Stewart GE, Macleod MA, Ironside JW, Cousens SN, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000; 47:575 - 582
   PubMed Web of Science ®Google Scholar
• Ingrosso L, Vetrugno V, Cardone F, Pocchiari M. Molecular diagnostics of transmissible spongiform encephalopathies. Trends Mol Med 2002; 8:273 - 280
   PubMed Web of Science ®Google Scholar
• Vincent B, Paitel E, Frobert Y, Lehmann S, Grassi J, Checler F. Phorbol ester-regulated cleavage of normal prion protein in HEK293 human cells and murine neurons. J Biol Chem 2000; 275:35612 - 35616
   PubMed Web of Science ®Google Scholar
• Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM, Kellermann O. Signal transduction through prion protein. Science 2000; 289:1925 - 1928
   PubMed Web of Science ®Google Scholar
• Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, et al. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 1987; 61:3688 - 3693
   PubMed Web of Science ®Google Scholar
• George M, Carlone MLT, Rumschlag Hella S, Sottnek Frances O. Rapid Microprocedure for Isolating Detergent-Insoluble Outer Membrane Proteins from Haemophilus Species. Journal of Clinical Microbiology 1986; 24:330 - 332
   PubMed Web of Science ®Google Scholar
• Tsukui K, Takata M, Tadokoro K. A potential blood test for transmissible spongiform encephalopathies by detecting carbohydrate-dependent aggregates of PrPres-like proteins in scrapie-Infected hamster plasma. Microbiol Immunol 2007; 51:1221 - 1231
   PubMed Web of Science ®Google Scholar
• Yuan J, Xiao X, McGeehan J, Dong Z, Cali I, Fujioka H, et al. Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J Biol Chem 2006; 281:34848 - 34858
   PubMed Web of Science ®Google Scholar